Brain cancer associated with a viral infection was found in two people with scleroderma…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
The molecule lysyl oxidase (LOX) plays key roles in promoting skin and lung scarring in…
Treatment with abatacept led to a reduction in skin stiffening and disability, as well as…
Rituximab, in combination with CellCept (mycophenolate mofetil), reverses the decline in lung…
A triple combination of prednisolone, cyclophosphamide and plasma exchange (plasmapheresis) was effective against skin thickening in seven…
EHP-101, an oral therapy based on cannabidiol (CBD),…
A statistical model applied to a widely used measure of skin thickening in people newly diagnosed with…
Immune players known as dendritic cells play a key role in scleroderma development in the skin and may…
Localized scleroderma affects health-related quality of life (HRQoL) in young people,…
A large-scale DNA analysis in different tissues revealed an association between scleroderma and groups of genes driving well-known inflammation pathways.